US Patent Issued to Genzyme on Oct. 6 for "5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity" (New Jersey Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,171, issued on Oct. 6, was assigned to Genzyme Corp. (Cambridge, Mass.).

"5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity" was invented by Junkai Liao (Bridgewater, N.J.), Mark Munson (Bridgewater, N.J.), Zhongli Gao (Bridgewater, N.J.), Gregory Donald Hurlbut (Bridgewater, N.J.), Sylvie Baltzer (Bridgewater, N.J.), Bertrand Vivet (Bridgewater, N.J.), Brian Freed (Bridgewater, N.J.), Hans Peter Nestler (Bridgewater, N.J.), Helen Yeoman (Bridgewater, N.J.), Ingrid Mechin (Bridgewater, N.J.), Martin Smrcina (Bridgewater, N.J.), Nina Ma (Bridgewater, N.J.), Sylvain Lebreton (Bridgewater, N.J.), Ryan Hartung (Bridgewater, N.J.), Willia...